US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday.

They could cost up CA$ 75 to 200. Which is roughly up to $145 in U.S. currency.

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...